3/28/2006

In a move that could strengthen its presence in eastern Europe, Sanofi-Aventis bought a one-quarter interest in Zentiva of the Czech Republic for about $515 million. The purchase by the French company would allow it to bundle branded and generic drugs.

Full Story:
BBC

Related Summaries